A ‘Plug-and-Play’ CRISPR Therapy for Flu and COVID
Published in
3 min readMar 9, 2021
The mRNA treatment can be rolled out rapidly in the event of a pandemic.
Researchers have developed a CRISPR treatment that could potentially treat both viruses that cause COVID-19 and influenza. The therapeutic comes in the form of a very fine mist that the patient can inhale, similar to an asthma inhaler, making it easy for patients to take at home.
